Mkts

Nektar Therapeutics

NASDAQ: NKTR
$37.83+0.56 (+1.52%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
36.6238.30
52-week range
33.40109.00
Today
Open37.27
Previous close37.83
Volume469.6K
Valuation
Market cap1.27B
P/E ratio—
EPS (TTM)-6.60
Income & risk
Dividend / yield—
Beta1.35
Avg volume1.01M
Discussion

NKTR News

Stories mentioning NKTR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue10,86121,80711,79011,17510,46029,17524,12423,489
Cost of Goods Sold0.000.000.000.007,9774,4359,740
Gross Profit21,80711,79011,17510,46021,19819,68913,749
Operating Expenses
Research & Development35,68029,71227,25229,88630,48028,74535,03129,724
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(39,054)(27,665)(31,672)(36,230)(44,535)14,348(34,345)(49,774)
Interest Income4,2422,7762,8191,9692,8742,9423,4373,901
Interest Expense
Other Expense(336.00)(44.00)(121.00)260.00266.00(135.00)(120.00)(36.00)
Pretax Income7,002(37,048)(52,317)
Tax Provision64.0031.00(33.00)(188.00)52.00(259.00)9.0046.00
Net Income (Loss)(44,904)(36,079)(35,522)(41,593)(50,882)7,261(37,057)(52,363)
Earnings Per Share (Basic)(1.82)(2.14)(1.87)(2.95)(3.62)0.53(2.66)(3.76)
Earnings Per Share (Diluted)(1.82)(2.14)(1.87)(2.95)(3.62)0.53(2.66)(3.76)
Weighted Average Shares Outstanding (Basic)24,73616,87118,94714,08714,06313,71113,95013,921
Weighted Average Shares Outstanding (Diluted)24,73616,87118,94714,08714,06313,71113,95013,921

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NKTR

Nektar Therapeutics (NASDAQ: NKTR) is a stock listed on the Nasdaq Stock Market under the ticker symbol NKTR. It last traded at $37.83 (Nov 9, 2026, 4:00 PM ET), up 1.5% on the day. That gives Nektar Therapeutics a market capitalisation of $1.3B.

Over the past 52 weeks NKTR has traded between $33.40 and $109.00.

Revenue for the quarter ended Mar 31, 2026 was $10.9M; a net loss of $44.9M. Revenue was up 3.8% from $10.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$10.9M-$44.9M-413.4%
Dec 31, 2025$21.8M-$36.1M-165.4%
Sep 30, 2025$11.8M-$35.5M-301.3%
Jun 30, 2025$11.2M-$41.6M-372.2%

From Nektar Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…